These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

367 related items for PubMed ID: 25667245

  • 1. Timing of opioid administration as a quality indicator for pain crises in sickle cell disease.
    Mathias MD, McCavit TL.
    Pediatrics; 2015 Mar; 135(3):475-82. PubMed ID: 25667245
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Use of a clinical pathway to improve the acute management of vaso-occlusive crisis pain in pediatric sickle cell disease.
    Ender KL, Krajewski JA, Babineau J, Tresgallo M, Schechter W, Saroyan JM, Kharbanda A.
    Pediatr Blood Cancer; 2014 Apr; 61(4):693-6. PubMed ID: 24249617
    [Abstract] [Full Text] [Related]

  • 4. Lactate Dehydrogenase: A Marker of the Severity of Vaso-Occlusive Crisis in Children with Sickle Cell Disease Presenting at the Emergency Department.
    García-Morin M, López-Sangüos C, Vázquez P, Alvárez T, Marañón R, Huerta J, Cela E.
    Hemoglobin; 2016 Nov; 40(6):388-391. PubMed ID: 28361592
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Oral morphine protocol for sickle cell crisis pain.
    Conti C, Tso E, Browne B.
    Md Med J; 1996 Jan; 45(1):33-5. PubMed ID: 8569458
    [Abstract] [Full Text] [Related]

  • 7. Pain management trend of vaso-occulsive crisis (VOC) at a community hospital emergency department (ED) for patients with sickle cell disease.
    Inoue S, Khan I, Mushtaq R, Sanikommu SR, Mbeumo C, LaChance J, Roebuck M.
    Ann Hematol; 2016 Jan; 95(2):221-5. PubMed ID: 26611852
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Impact of an emergency department pain management protocol on the pattern of visits by patients with sickle cell disease.
    Givens M, Rutherford C, Joshi G, Delaney K.
    J Emerg Med; 2007 Apr; 32(3):239-43. PubMed ID: 17394984
    [Abstract] [Full Text] [Related]

  • 14. Pain management in adults with sickle cell disease in a medical center emergency department.
    Solomon LR.
    J Natl Med Assoc; 2010 Nov; 102(11):1025-32. PubMed ID: 21141290
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Treatment of uncomplicated vaso-occlusive crises in children with sickle cell disease in a day hospital.
    Raphael JL, Kamdar A, Beavers MB, Mahoney DH, Mueller BU.
    Pediatr Blood Cancer; 2008 Jul; 51(1):82-5. PubMed ID: 18383165
    [Abstract] [Full Text] [Related]

  • 17. Opioid doses and acute care utilization outcomes for adults with sickle cell disease: ED versus acute care unit.
    Molokie RE, Montminy C, Dionisio C, Farooqui MA, Gowhari M, Yao Y, Suarez ML, Ezenwa MO, Schlaeger JM, Wang ZJ, Wilkie DJ.
    Am J Emerg Med; 2018 Jan; 36(1):88-92. PubMed ID: 28802541
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Impact of individualized pain plan on the emergency management of children with sickle cell disease.
    Krishnamurti L, Smith-Packard B, Gupta A, Campbell M, Gunawardena S, Saladino R.
    Pediatr Blood Cancer; 2014 Oct; 61(10):1747-53. PubMed ID: 24962217
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.